■ March 4, Thursday
■ March 5, Friday

■ March 5, Friday ( 6th floor, GTC 9:30 - 17:20 )
Plenary Talk U and Joint SessionU 9:30-12:10 〔160〕
Chairs: Shinya Suzu and Keiko Sakai
19 Tao Dong
[ University of Oxford, UK ]
Extensive HLA-driven viral diversity following a single-source HIV-1 outbreak in rural China

20 Hirotomo Nakata
[ National Cancer Institute, USA ]
CCR5 receptors form functional clusters upon their interactions with HIV gp120/gp41 trimers

21 Shogo Misumi
[ Kumamoto Univ. ]
UNCOATING OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REQUIRES PROLYL ISOMERASE PIN1

22 Kosuke Miyauchi
[ National Institute of Infectious Diseases ]
The productive endocytosis of HIV-1

23 Joseph Ziegelbauer
[ National Cancer Institute, USA ]
Human target genes of viral microRNAs expressed by Kaposi's sarcoma-associated herpesvirus


Parallel SessionX:
Immune ResponsesU
14:10-15:30 〔80〕
Chairs: Masao Hashimoto and Hayato Murakoshi
24 Hiroyuki Yamamoto
[ University of Tokyo ]
Non-sterile SIV control by neutralizing antibodies: windows period for a B-to-T.

25 Teppei Toda
[ Kumamoto Univ. ]
Inhibition of HIV-1 infection by novel anti-CD4 monoclonal antibody

26 Philip Mwimanzi
[ Kumamoto Univ. ]
The effects of CTL-escape conferring mutations on Nef's pathogenic functions in primary macrophages.

27 Kazutaka Honda
[ Kumamoto Univ. ]
Selection of escape mutant by HLA-C-restricted HIV-1 Pol-specific cytotoxic T lymphocytes having a strong ability to suppress HIV-1 replication

Parallel SessionY:
Immune ResponsesV
16:00-17:10 〔70〕
Chairs: Masumichi Saito and Chihiro Motozono
28 Maximillian Rosario
[ University of Oxford, UK ]
Long peptides induce polyfunctional T cells against conserved regions of HIV-1 with superior bredth to single-gene vaccines in macaques

29 Nan Zheng
[ Kumamoto Univ. ]
Roles of CD4+ T Cells in the Control of HIV Infection: The Victim Strikes Back

30 Keiko Sakai
[ Kumamoto Univ. ]
Correlation between nadir CD4 counts and skewed distributions of CD4+ T-cell subsets in patients chronically infected with HIV-1

Closing Remark

■ March 5, Friday ( 2nd floor, CAIDS 14:10 - 17:20 )
Parallel SessionZ:
Therapy and Epidemiology
14:10-15:30 〔80〕
Chairs: Hiroyuki Gatanaga and Kazuhiko Ide
31 Takeshi Nishijima
[ International Medical Center of Japan ]
The impact of Tenofovir disoproxil fumarate on renal function among Japanese patients with HIV-1 infection

32 Tamayo Watanabe
[ International Medical Center of Japan ]
Trends of AIDS indicative diseases, malignancies, and cause of death in HIV-1-infected patients in Japan

33 Jagdagsuren Davaalkham
[ International Medical Center of Japan ]
Current status of HIV infection in Mongolia: Expanding trend of HIV-1 subtype B among MSM

34 Shiro Ibe
[ Nagoya Medical Center ]
Identification of the first circulating recombinant form of HIV-2, CRF01_AB

Parallel Session[:
PathogenesisU
16:00-17:10 〔70〕
Chairs: Takeo Kuwata and Masateru Hiyoshi
35 Ken Kono
[ Osaka Univ. ]
Viral and host determinants for the restriction of human immunodeficiency virus type 2/simian immunodeficiency virus SIVmac by rhesus monkey TRIM5α

36 Taisuke Izumi
[ Kyoto Univ. ]
A novel HIV-1 Vif function is mediated by interaction with oncoprotein p53

37 Terumasa Ikeda
[ Kumamoto University ]
Intrinsic restriction activity by apolipoprotein B mRNA editing enzyme APOBEC1 against the mobility of autonomous retrotransposons


Closing Remark


前のページへ戻る ページのトップへ